Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
NCT00190424
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
CpG-ODN
Sponsor
Assistance Publique - Hôpitaux de Paris